Ovid Therapeutics, Inc. (OVID)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
Aug 28, 16:00
2.77
-0.03
(-1.07%)
After-Hours: 04:23
Ovid Therapeutics Price to Book Value : 2.465 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.465 |
| August 27, 2026 | 2.579 |
| August 26, 2026 | 2.535 |
| August 25, 2026 | 2.562 |
| August 24, 2026 | 2.482 |
| August 21, 2026 | 2.465 |
| August 20, 2026 | 2.412 |
| August 19, 2026 | 2.579 |
| August 18, 2026 | 2.500 |
| August 17, 2026 | 2.544 |
| August 14, 2026 | 2.491 |
| August 13, 2026 | 2.465 |
| August 12, 2026 | 2.306 |
| August 11, 2026 | 2.271 |
| August 10, 2026 | 2.306 |
| August 07, 2026 | 2.315 |
| August 06, 2026 | 2.333 |
| August 05, 2026 | 2.306 |
| August 04, 2026 | 2.236 |
| August 03, 2026 | 2.051 |
| July 31, 2026 | 1.954 |
| July 30, 2026 | 2.086 |
| July 29, 2026 | 2.016 |
| July 28, 2026 | 2.077 |
| July 27, 2026 | 2.069 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.051 |
| July 23, 2026 | 2.113 |
| July 22, 2026 | 2.095 |
| July 21, 2026 | 2.121 |
| July 20, 2026 | 2.029 |
| July 17, 2026 | 2.148 |
| July 16, 2026 | 2.157 |
| July 15, 2026 | 2.192 |
| July 14, 2026 | 2.165 |
| July 13, 2026 | 2.139 |
| July 10, 2026 | 2.218 |
| July 09, 2026 | 2.289 |
| July 08, 2026 | 2.403 |
| July 07, 2026 | 2.430 |
| July 06, 2026 | 2.298 |
| July 02, 2026 | 2.368 |
| July 01, 2026 | 2.359 |
| June 30, 2026 | 2.368 |
| June 29, 2026 | 2.295 |
| June 26, 2026 | 2.151 |
| June 25, 2026 | 2.042 |
| June 24, 2026 | 2.109 |
| June 23, 2026 | 1.957 |
| June 22, 2026 | 1.898 |
| June 18, 2026 | 1.915 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
| Anika Therapeutics, Inc. | 2.057 |
| Savara, Inc. | 7.520 |
| Vericel Corp. | 5.663 |
Price to Book Value Related Metrics
| PS Ratio | 215.09 |
| Price | 2.80 |
| Earnings Yield | -9.05% |
| Market Cap | 517.32M |